Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Related Articles
Commentaries
MAKE A COMMENT
All fields required
More Views
- Cuba could become a BRICS partner country in 2025, according to Russia
- The harsh account of a U.S. doctor who broke down in tears before a UN committee explaining the situation in Gaza
- Brazil’s former defense minister arrested in attempted coup probe
- Palestinian Football Association denounces consequences of Israeli aggression against sport in Gaza
- Outgoing U.S. President Joe Biden commutes sentences of 1,500... but what about Leonard Peltier?
